BullFrog AI Holdings, Inc. (BFRG): Total Liabilities
$672.0K
As of 2025-12-31
$706.6K
As of 2026-06-30
-40.2%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $672.0K | +14.3% | 2026-03-19, Balance as of period end |
| 2024-12-31 | $588.1K | +219.0% | 2026-03-19, Balance as of period end |
| 2023-12-31 | $184.3K | -94.1% | 2025-03-14, Balance as of period end |
| 2022-12-31 | $3.14M | +207.9% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $1.02M | n/a | 2023-04-25, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $672.0K | +14.3% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.99M | +12.4% |
| iBio, Inc. (IBIO) | 2026-06-30 | $13.40M | +61.3% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $43.94M | -0.5% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $7.06M | +21.1% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $3.14M | -44.7% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $1.30M | -45.3% |
| Clene Inc. (CLNN) | 2025-12-31 | $35.72M | -1.3% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $50.21M | +12.4% |
Compare BFRG, SER, IBIO, ATNM side by side · Screen every company in Pharmaceutical Preparations ↗